The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Comprehensive analysis of kinase inhibitor selectivity.EBI
Ambit Biosciences
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.EBI
Universite de Tours
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial EBI
University of North Carolina At Chapel Hill
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline
Plasmodial Kinase Inhibitors: License to Cure?EBI
TBA
Compounds as diacylglycerol acyltransferase inhibitorsBDB
Glaxosmithkline
In vivo and in vitro effect of androstene derivatives as 5a-reductase type 1 enzyme inhibitors.BDB
National University of Mexico City
D3 dopamine receptor agonists to treat dyskinesia in parkinson's diseaseBDB
Drexel University